YY-351
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for YY-351, covering 2019-02-25 to 2019-02-25. Get the full timeline:
Most recent: Clinical Trial Update: A Dose-Finding, Efficacy and Safety Study of YY-351 in Patients With Type 2 Diabetes [Phase 2]